An operator rested their arms on the work surface of the hood during aseptic production.
Inspection Record
VA San Diego Healthcare Systems — FDA 483 Findings
Inspectors Cecilia H. Kieu · Matthew R. ClabeauxThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Production areas have difficult to clean or contain porous, particle generating, or visibly dirty equipment or surfaces.
Lack of disinfection of supplies at each transition from areas of lower quality air to areas of higher quality air.
Personnel were observed touching equipment or other surfaces located outside of the ISO 5 area with gloved hands and then proceeding with aseptic processing without changing or sanitizing gloves.
Beta-lactam drugs were produced without providing adequate containment, segregation, and/or cleaning of work surfaces, utensils, and/or personnel to prevent cross-contamination.
Personnel performed aseptic manipulations with exposed hair or skin.
Contamination was observed in your production area.
Materials were exposed to lower than ISO 5 quality air.
Personnel engaged in aseptic processing were observed wearing non-sterile gloves.
Personnel were observed moving quickly in a critical area or in an area immediately adjacent to a critical area likely causing disruption of unidirectional airflow.
About this record
Extracted automatically from the document US FDA published on 2026-07-06. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
